companydata.dkcompanydata.dk

ZEMA Pharma Consulting ApS: Financial statements 2022

CVR: 42680427

Source: annual report 2022, Danish Business Authority

15/09/2021 – 30/09/2022

ZEMA Pharma Consulting ApS (CVR 42680427) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,146,083 and a net result of DKK 789,558. Equity in the 2022 report amounted to DKK 829,558. The solvency ratio was 69.9%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,146,083
Profit/Loss
DKK 789,558
Equity
DKK 829,558
Total Assets
DKK 1,187,225
Employees
1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ZEMA Pharma Consulting ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About ZEMA Pharma Consulting ApS

ZEMA Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Torkild Hansen. The company is owned by Mads Torkild Hansen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 102,227 and a net result of DKK -216,744 compared with DKK -281,625 the year before. Equity in the 2025 report amounted to DKK 354,543.

Source: annual report 2025, Danish Business Authority

Other financial years